Norway· NO-ID_A163BE25-FD92-4EAE-B853-B6527807B43C
Finlee
A dabrafenib product containing dabrafenib, registered in Norway by Novartis Europharm Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Dabrafenib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EC02 (dabrafenib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Dabrafenib · ATC L01EC02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dabrafenib costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dabrafenib · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$232.39
The record
At a glance
FEST (Norway)- Active substance
- Dabrafenib
- Manufacturer
- Novartis Europharm Limited
- Country
- Norway (NO)
- ATC code
- L01EC02
- ATC class
- Dabrafenib
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_A163BE25-FD92-4EAE-B853-B6527807B43C
- no_varenummer5306472 x 210NOK 44146.2
- gtin7613421107574
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
522 interactions on record for dabrafenib.
Graded by severity as the source publishes them — 79 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dabrafenib · interactions on record
522 records
- 79 severe
- 430 moderate
- 13 minor
Most severe, free to view
- LonafarnibA16AX20severe
- AvatrombopagB02BX08severe
- VoxelotorB06AX03severe
- RanolazineC01EB18severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dabrafenib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumFinlee 10 mgNovartis Europharm
- CanadaTAFINLARNOVARTIS PHARMACEUTICALS CANADA INC
- SwitzerlandTafinlar 10 mg, Tablette zur Herstellung einer Suspension zum EinnehmenNovartis Pharma Schweiz AG
- SpainFINLEE 10 MG COMPRIMIDOS DISPERSABLESNovartis Europharm Limited
- FinlandFinleeNovartis Europharm Limited
- FranceFINLEE 10 mg, comprimé dispersibleNOVARTIS EUROPHARM (IRLANDE)
- United KingdomFinlee 10mg dispersible tabletsNovartis Pharmaceuticals UK Ltd
- IrelandFinlee 10 mg dispersible tabletsNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Finlee, Tafinlar
- Liechtenstein · Finlee, Tafinlar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5eb8ac8-f1b9-4139-af7c-cbdcb3a4cf47 GET /v1/drugs/e5eb8ac8-f1b9-4139-af7c-cbdcb3a4cf47?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispergerbar tablett",
"source": "fest",
"status": "A",
"atc_name": "Dabrafenib",
"merkevare_id": "ID_A163BE25-FD92-4EAE-B853-B6527807B43C",
"name_form_strength": "Finlee disperg tab 10 mg",
"prescription_group": "C"
}See everything about dabrafenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.